白三烯B4-BLT1轴促进系统性硬化症肌成纤维细胞分化与组织纤维化
该研究比较了64例系统性硬化症(SSc)患者与80例健康对照的血清白三烯B4(LTB4)水平,并在SSc小鼠模型中干预LTB4-BLT1轴。结果显示SSc患者血清LTB4升高44.93%,且与SSc相关间质性肺病和弥漫性皮肤型SSc亚组相关;干预该轴可减轻小鼠皮肤和肺纤维化,机制涉及PI3K/Akt/mTOR通路且不依赖TGFβ自分泌。
要点
- SSc患者血清LTB4较健康对照升高44.93%,与SSc-ILD和弥漫性皮肤型SSc相关。
- 干预LTB4-BLT1轴可减轻小鼠皮肤和肺纤维化,减少α-SMA阳性肌成纤维细胞积聚。
- LTB4通过BLT1激活PI3K/Akt/mTOR通路促进肌成纤维细胞分化,不依赖TGFβ自分泌。
核心结论
- LTB4-BLT1轴可能通过PI3K/Akt/mTOR通路直接促进肌成纤维细胞分化,从而参与SSc纤维化,且似乎不依赖TGFβ自分泌。
研究设计与样本
- 比较64例SSc患者与80例健康对照的血清LTB4水平,并对SSc患者和健康供者皮肤及肺组织切片进行免疫染色。
- 使用博来霉素、血管紧张素II或DNA拓扑异构酶I免疫的小鼠SSc模型,通过遗传或药理方式阻断LTB4-BLT1轴。
- 对成纤维细胞和内皮细胞进行免疫印迹,检测LTB4或SSc患者血清刺激后的信号通路。
主要发现
- SSc患者血清LTB4水平较匹配健康对照高44.93%(均值±标准差220.3±74.75 pg/ml vs 152.0±68.05 pg/ml;P<0.0001)。
- 血清LTB4升高与SSc相关间质性肺病和弥漫性皮肤型SSc患者亚组相关。
- SSc患者皮肤和肺病变区域LTA4H和BLT1水平升高,二者在肌成纤维细胞和内皮细胞中均丰富。
- 博来霉素攻击后,阻断LTB4-BLT1轴使小鼠皮肤和肺中α-平滑肌肌动蛋白阳性肌成纤维细胞分别减少54.00%和52.65%。
- 重组LTB4或SSc患者血清刺激的成纤维细胞和内皮细胞中,成纤维细胞-肌成纤维细胞转化和内皮-间质转化通过BLT1促进,依赖PI3K/Akt/mTOR通路激活,不依赖成纤维细胞或内皮细胞释放TGFβ。
临床怎么用
- LTB4-BLT1轴及下游PI3K/Akt/mTOR通路可能作为SSc纤维化的潜在干预靶点。
- 血清LTB4水平与SSc-ILD和弥漫性皮肤型SSc亚组相关,提示其作为疾病亚型相关生物标志物的可能性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the role of the inflammatory lipid mediator leukotriene B4 (LTB4 ) and its receptor, BLT1, in the development and progression of systemic sclerosis (SSc). METHODS: Serum levels of LTB4 were compared in 64 patients with SSc and 80 healthy controls. Skin and lung tissue sections from patients with SSc and healthy donors were immunostained for leukotriene A4 hydrolase (LTA4 H), the critical enzyme for LTB4 synthesis, and BLT1, in combination with different cell markers. In mouse models of SSc using bleomycin or angiotensin II challenge or immunization with the DNA topoisomerase I, genetic or pharmacologic interruption of the LTB4 -BLT1 axis in mice was carried out to assess its effects on systemic disease features and myofibroblast markers. Immunoblotting was performed to examine the signaling pathway in fibroblasts and endothelial cells following stimulation with LTB4 or with serum from SSc patients. RESULTS: Serum LTB4 levels were 44.93% higher in patients with SSc than in matched healthy controls (mean ± SD 220.3 ± 74.75 pg/ml versus 152.0 ± 68.05 pg/ml; P < 0.0001), and this was associated with the patient subsets of SSc-associated interstitial lung disease and diffuse cutaneous SSc. Levels of LTA4 H and BLT1 were increased in lesional areas of the skin and lungs of SSc patients, and both were abundant in myofibroblasts and endothelial cells. Interruption of the LTB4 -BLT1 axis in mouse models of SSc significantly mitigated dermal and pulmonary fibrosis, with 54.00% and 52.65% fewer α-smooth muscle actin-positive myofibroblasts accumulating in the skin and lungs of mice, respectively, after bleomycin challenge. Immunoblotting of cultures with recombinant LTB4 -stimulated fibroblasts and endothelial cells or with serum from SSc patients showed that fibroblast-myofibroblast and endothelial-mesenchymal transitions were promoted via BLT1, and that this was dependent on activation of the phosphatidylinositol 3-kinase (PI3K)/Akt/mechanistic target of rapamycin (mTOR) pathway but independent of the release of transforming growth factor β (TGFβ) by fibroblasts or endothelial cells. CONCLUSION: The LTB4 -BLT1 axis may contribute to fibrosis in SSc by directly promoting myofibroblast differentiation via the PI3K/Akt/mTOR pathway, and this appears to operate independently of autocrine secretion of TGFβ.
引用
- Liang M, Lv J, Jiang Z, et al. Promotion of Myofibroblast Differentiation and Tissue Fibrosis by the Leukotriene B4 -Leukotriene B4 Receptor Axis in Systemic Sclerosis. Arthritis Rheumatol. 2020. PMID: 31872544. doi:10.1002/art.41192
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。